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Cyclooxygenase-2–Dependent Prostacyclin Formation and
Blood Pressure Homeostasis
Targeted Exchange of Cyclooxygenase Isoforms in Mice
Ying Yu, Jane Stubbe, Salam Ibrahim, Wen-liang Song, Emer M. Symth,
Colin D. Funk, Garret A. FitzGerald
Rationale: Cyclooxygenase (COX)-derived prostanoids (PGs) are involved in blood pressure homeostasis. Both
traditional nonsteroidal antiinflammatory drugs (NSAIDs) that inhibit COX-1 and COX-2 and NSAIDs designed
to be selective for inhibition of COX-2 cause sodium retention and elevate blood pressure.
Objective: To elucidate the role of COX-2 in blood pressure homeostasis using COX-1>COX-2 mice, in which the
COX-1 expression is controlled by COX-2 regulatory elements.
Methods and Results: COX-1>COX-2 mice developed systolic hypertension relative to wild types (WTs) on a
high-salt diet (HSD); this was attenuated by a PGI2 receptor agonist. HSD increased expression of COX-2 in WT
mice and of COX-1 in COX-1>COX-2 mice in the inner renal medulla. The HSD augmented in all strains
urinary prostanoid metabolite excretion, with the exception of the major PGI2 metabolite that was suppressed on
regular chow and unaltered by the HSD in both mutants. Furthermore, inner renal medullary expression of the
receptor for PGI2, but not for other prostanoids, was depressed by HSD in WT and even more so in both mutant
strains. Increasing osmolarity augmented expression of COX-2 in WT renal medullary interstitial cells and again
the increase in formation of PGI2 observed in WTs was suppressed in cells derived from both mutants.
Intramedullary infusion of the PGI2 receptor agonist increased urine volume and sodium excretion in mice.
Conclusions: These studies suggest that dysregulated expression of the COX-2 dependent, PGI2 biosynthesis/
response pathway in the renal inner renal medulla undermines the homeostatic response to a HSD. Inhibition of
this pathway may contribute directly to the hypertensive response to NSAIDs. (Circ Res. 2010;106:337-345.)
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Prostaglandins contribute to blood pressure (BP) ho-meostasis via their direct effects on vascular tone and on
fluid and electrolyte transport in the kidney. Nonsteroidal
antiinflammatory drugs (NSAIDs) block prostanoid (PG)
biosynthesis by inhibition of the activity of the cyclooxygen-
ase (COX) isozymes COX-1 and COX-2.1 Both traditional
(t)NSAIDs and those designed to be selective for inhibition of
COX-2 may increase systemic BP and/or undermine BP
control with antihypertensive drugs.2,3 PG formation is gen-
erally reactive and elaboration of vasodilator PGs preserves
renal blood flow in renoprival conditions.4 Similarly,
NSAIDs, in vulnerable populations, such as the elderly or in
response to a hypertensive stimulus, such as a high-salt diet
(HSD), decrease total renal perfusion and cause redistribution
of renal blood flow.5 This may lead to medullary ischemia,
and even acute renal failure.6 Even short-term studies of
NSAIDs in apparently healthy, but susceptible, populations
may result in decreased glomerular filtration rate and urinary
sodium retention.7
In rodents, COX-1 deletion causes natriuresis, accentuates
the effects of angiotensin converting enzyme inhibitors, and
reduces BP despite activation of the renin–angiotensin sys-
tem.8 Indeed, both pharmacological inhibition and genetic
deletion of COX-1 abolish the hypertensive response to
angiotensin II in mice.9,10 Deletion or inhibition of COX-2, by
contrast, reduces renal medullary blood flow and sodium
excretion, increases the vasoconstrictive response to angio-
tensin II,10 and elevates basal BP.11 These observations have
prompted the suggestion that hypertension on NSAIDs is a
function of both inhibition of COX-2 and the selectivity with
which it is attained.12 Although this is consistent with some
evidence,3,13 both the relative importance of selectivity and
the mechanism by which COX-2 preserves BP homeostasis
remain to be rigorously addressed.
Although the COX isozymes are structurally similar, their
method of regulation is quite distinct.1 One mechanism by
which COX-2 might play a role in BP homeostasis is by its
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ready induction in renal medullary interstitial cells (RMICs)
where it is coexpressed with COX-114 and induced by high
salt or fluid deprivation.15,16 Inhibition of medullary COX-2
in rats17,18 or global deletion of the PGI2 receptor (IP)19,20 or
the EP2 PGE2 receptor21,22 in mice results in salt-sensitive
hypertension. We designed COX-1COX-2 mice23 to ad-
dress the hypothesis that dysregulated expression of COX-2,
rather than structural distinctions of COX-224 from COX-1,
might have relevance to BP homeostasis. Our results support
the notion that dysregulated expression of the COX-2 depen-
dent, PGI2 biosynthesis/response pathway in the renal inter-
nal medulla undermines the homeostatic response to a HSD.
Inhibition of this pathway may contribute directly to the
hypertensive response to NSAIDs.
Methods
An expanded Methods section is available in the Online Data
Supplement at http://circres.ahajournals.org.
Mice
All COX-1COX-2 and COX-2 null mice used for the experiments
were initially produced on a mixed C57BL/6 x Sv129 genetic
background (50%:50%). All procedures were approved by the
Institutional Animal Care and Use Committee of the University
of Pennsylvania.
BP Measurement
Resting systolic blood was measured in conscious mice using a
computerized noninvasive tail cuff system (Visitech Systems Inc) as
previously described.11
Analysis of Renal Medullar Perfusion and Urinary
Sodium Excretion
Mice were anesthetized with a mixture of ketamine (100 mg/kg) and
xylazine (10 mg/kg IM), and the right kidney was removed. After 1
week of recovery, catheters were implanted in the jugular vein,
bladder and renal medullary interstitium as described previously.25
Saline or cicaprost tested compound was infused into the renal
medulla at 20 L/h. After 1 hour of equilibration, urine was collected
every 30 minutes. Urinary sodium concentration was determined by
Electrolyte Analyzer (PL 1000B).
Statistical Analysis
Data are presented as meansSEM. Analyses were performed by the
ANOVA and subsequent pairwise comparisons as appropriate. A
probability value of 0.05 was considered significant. Prism 4.0
software (GraphPad InStat 3) was used for all the calculations.
Results
COX-1 Rescues the BP and Renin Response to COX-2
Deletion on a Normal Diet but Not on a HSD
COX-2– deficient mice exhibited systolic hypertension
(145.05.4 mm Hg versus wild-type [WT] littermates,
122.07.8 mm Hg; P0.01; Figure 1A and Online Figure I),
whereas BP was unaltered in COX-1COX-2 mice BP
(127.05.5 mm Hg versus WT littermates, 123.34.4 mm Hg;
Figure 1A) on a normal chow diet. These results indicate COX-1
could substitute for COX-2 in maintaining BP homeostasis
under physiological conditions. This is also consistent with the
ability of COX-1 under the COX-2 promoter to rescue impaired
renal development, characteristic of COX-2–null mice.23,26
The renal cortical hypoplasia and biochemical evidence of
renal dysfunction in COX-2 knockouts (KOs) was absent in
COX-1COX-2 mice (Online Figure II). However, in response
to the HSD, COX-1COX-2 mice developed hypertension
(149.77.3 mm Hg versus WT, 128.16.5 mm Hg, P0.05,
n9 to 12; Figure 1A), just like COX-2 KOs (151.0
2.9 mm Hg; P0.05). Thus, although COX-1 could rescue the
renal developmental impact of COX-2 deficiency, including
hypertension on a chow diet, it was unable to compensate for the
Non-standard Abbreviations and Acronyms
BP blood pressure
EC endothelial cell
HSD high-salt diet
IP prostanoid I2 receptor
KO knockout
NSAID nonsteroidal antiinflammatory drug
pdNSAID NSAID purposefully developed to inhibit selectively COX-2
PG prostanoid
RMIC renal medullary interstitial cell
tNSAID traditional NSAID
Tx thromboxane
WT wild type
Figure 1. Effects of normal or HSD on BP and renin expression in COX-1COX-2, COX-2 KO, and WT mice. A, Systolic BP was mea-
sured in conscious COX-1COX-2, WT and COX-2 KO mice by tail cuff (n9 to 12 for each group). Mice (6 to 7 weeks old) were fed
either a normal chow diet (0.7% NaCl) or a HSD (8% NaCl) for 2 weeks. *P0.05 vs WT controls; #P0.05 vs normal diet. B, Quantita-
tive real-time RT-PCR was performed to analyze renin mRNA expression in the kidneys from COX-1COX-2, WT, and COX-2 KO mice.
*P0.05 vs WT controls; #P0.05 vs normal diet (n4 to 6).
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absence of COX-2 in regulating BP homeostasis in the face of a
high salt challenge.
Downstream products of COX-2 include renin secreta-
gogues, like PGI2.27,28 Renin expression was reduced on a
chow diet by 35% in COX-2 KO mice, and this phenotype
was rescued in COX-1COX-2 mice (P0.05; Figure 1B).
However, analogous to the BP response to HSD, the homeo-
static decline in renin observed in COX-2 KOs was not
rescued in the COX-1COX-2 mice.
Insertion of COX-1 Does Not Substitute for
COX-2–Derived Biosynthesis of PGI2
We have previously shown in mice and humans that COX-2 is
the dominant source of PGI2 biosynthesis, as measured by its
urinary metabolite, 2,3-dinor-6-keto PGF1 (PGIM).11,24 By
contrast, the major urinary metabolite of PGE2, 9,15-dioxo-11-
hydroxy-2,3,4,5-tetranor-prostane-1,20-dioic acid (PGEM), de-
rives from both COX-1 and COX-2.11 Deletion of COX-2
suppressed both urinary PGIM and PGEM in mice on a chow
diet. However, although COX-1 insertion could rescue the
decline in PGEM (1.720.38 ng/mg creatinine in COX-2 KO
versus 3.150.47 ng/mg creatinine in COX-1COX-2 versus
3.890.92 ng/mg creatinine in WT) (Figure 2A), it had no
impact on the suppression of urinary PGIM (Figure 2B). A
similar disparity in the ability of COX-1 to substitute for COX-2
applied under HSD conditions. HSD increased excretion of all
metabolites consistent with induction of COX-2 in renal medulla
(see below) in WT mice. Deletion of COX-2 had no impact on
excretion of major metabolites of either PGD2 (11,15-dioxo-
9-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid) or
thromboxane (Tx) (2,3-dinor-TxB2), both of which derive
predominantly from COX-1,29,30 on either chow or HSD
(Figure 2C and 2D).
Medullary COX-1 Expression in Response to HSD
in the Absence of COX-2
HSD is recognized to have divergent effects on expression of
COXs in kidney.15 As expected, the HSD had no significant
effect on WT COX-1 expression in both cortex and medulla
(Figure 3A and 3C), whereas it downregulated COX-2
expression in cortex and upregulated COX-2 in medulla in
WT mice (Figure 3B and 3D). Indeed, cortical expression of
COX-1 tended to be higher in the mutants on regular chow and
this change reached significance on a HSD. COX-2 expression
was absent, as expected, in both cortex and medulla in the
mutants (Figure 3B and 3D). By contrast, HSD upregulated
expression of COX-1 in the cortex of COX-1COX-2
(76030106/18S rRNA, P0.05) and COX-2 KO versus WT
(71745106/18S rRNA versus 50334106/18S rRNA,
P0.05) mice (Figure 3A) and of COX-1 in the medulla of
COX-1COX-2 (3768242106/18S rRNA versus 2302
167106/18S rRNA, P0.05), whereas it did not regulate
expression of medullary COX-1 when the isozyme was ex-
pressed under its own promoter (Figure 3C). Thus, COX-2 is
usually the dominant isoform regulated by HSD in the medulla.
Medullary COX-1 Cannot Restore the
COX-2–Dependent Capacity to Generate PGI2
Given the relevance of COX-2 in the renal medulla to BP
homeostasis,17,18 the tissue capacity to generate PGs was
assessed. This is quite distinct from estimation of systemic
PG biosynthesis, as reflected by urinary metabolites; the
capacity of tissues to generate PGs greatly exceeds actual
synthetic rates in vivo.31
The most abundant product was PGE2 (Figure 4). Both PGE2
and PGI2 (detected as 6-keto-PGF1) are vasodilators and PGI2
is also a potent renin secretagogue. Consistent with hypertension
and hyporeninemia (Figure 1A and 1B), the capacity to generate
these PGs is reduced in COX-2 KOs on a chow diet (Figure 4A
and 4C). By contrast, the rather trivial medullary capacity to
generate PGD2 and PGF2, both of which derive predominantly
from COX-1, is retained (Figure 4B and 4D).
HSD augments the capacity to generate renal medullary PGs
in WT mice. However, this capacity is attenuated in the case of
PGI2 in both mutant strains (Figure 4C). This indicates that
COX-2 is the dominant source of this PG and it cannot be
substituted for by COX-1 under these conditions. The HSD
induced increase in PGE2 is restrained only in COX-2 KOs,
Figure 2. Effect of high salt intake on PG biosynthe-
sis in COX-1COX-2, COX-2 KO, and WT mice.
Twenty-four-hour urine samples from COX-1COX-2,
COX-2 KO, and WT male mice (8 weeks old) were
collected; the urinary PGE2 metabolite (PGE-M) (A),
PGI2 metabolite (PGI-M) (B), PGD2 metabolite
(PGD-M) (C), Tx2 metabolite (Tx-M) (D) were mea-
sured. Data are presented as meansSEMs.
*P0.05 vs WT controls (n7 to 20).
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indicating the ability of COX-1 to compensate for COX-2 in the
generation of this PG. Given the failure of COX-1 insertion to
compensate for the BP effect of deletion of COX-2 (Figure 1),
these results implicate PGI2 as the dominant product of COX-2
restraining the hypertensive response to HSD.
Reduced Expression of the Medullary PGI2
Receptor on a HSD
Although the EP1 and EP3 receptors for PGE2 were, by far,
the most abundantly expressed in renal medulla, their expres-
sion was unaltered in the mutants or by HSD. This was also
true for the other receptors for PGE2 (EP2 and EP4) and also
for receptors for PGF2 (the FPs) and for PGD2 (the DP2).
Expression of DP1 was not detectable (Online Figure III).
Expression of the receptor for TxA2, the TP, was suppressed
compared to WT by COX-2 deletion on both chow and HSD
(Online Figure III), although this was not evident in the renal
cortex (Online Figure IV), where it is expressed in the
glomeruli.32 Pertinent to its proposed role in the hypertensive
response to HSD, medullary expression of the PGI2 receptor,
the IP, is depressed by HSD, even in WT mice and expression
of its transcript is detectably further depressed in both
mutants (Figure 5A). Accordingly, we observed IP protein
suppression by HSD was detectable in renal medulla, al-
though no significant difference detected among genotypes
(Figure 5B and 5C). Thus, decreased expression of the IP
could interact with depressed synthesis of PGI2 in the renal
medulla to underlie the hypertensive response to COX-2
Figure 3. Effect of high salt intake on COX-1 and
COX-2 expression in renal tissue obtained from
COX-1COX-2, COX-2 KO, and WT mice. COX-1
and COX-2 mRNA in renal cortex (A and B) and
inner medulla (C and D) were determined by real-
time RT-PCR. HS indicates HSD. *P0.05 vs WT
controls; #P0.05 vs normal diet (n4 to 6).
Figure 4. Effect of high salt intake on the
capacity of renal medulla to generate PGs.
Mice were fed a HSD or normal chow diet
for 2 weeks, and the renal medulla was
dissected and the PG profile (PGE2 [A],
PGD2 [B], 6-keto-PGF1 [C], PGF2 [D])
was analyzed by mass spectrometry.
*P0.05 vs WT controls (n5 to 8);
#P0.05 vs normal diet group (n5 to 8).
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deletion and the failure of COX-1 to compensate for this
deficiency. A similar pattern of decreased expression of the
IP in both mutants on HSD was observed in the renal cortex
(Online Figure IV), where it may be relevant to the attendant
hyporeninemia (Figure 1B).
IP Receptor Activation Restrains Salt-Induced
Hypertension in COX-1>COX-2 Mice
Systemic and renal PGI2 biosynthesis were impaired under
both basal and HSD conditions and renal IP receptor expres-
sion was further depressed by HSD in COX-1COX-2 mice.
To examine whether down-regulation of PGI2/IP signaling
contributes to salt-sensitive hypertension in COX-2 mutant
mice, COX-1COX-2 mice were subcutaneously infused
with the IP specific agonist, cicaprost (50 g/kg per day),
using an osmotic minipump. BP was recorded before implan-
tation and after exposure to a HSD by tail cuff. Systolic BP in
COX-1COX-2 mice was elevated markedly by the HSD
and this effect was significantly attenuated by cicaprost
infusion (from 140.84.1 to 119.44.2 mm Hg, P0.01,
n9; Online Figure V).
Differential Substitution of COX-1 for Hypertonic
Induction of COX-2–Dependent PG Formation
in RMICs
In rodents, COX-2 expression is restricted in RMICs in renal
medulla.14 RMICs were isolated to address the impact of
COX-1 substitution for COX-2 in an in vitro model of
regulated expression of COX-2. The RMICs derived from
COX-2 KOs were hypersensitive to cell dissociation, more
than 45% of 3rd passage COX-2 KO RMICs died when
treated with 0.025% trypsin/0.5 mmol/L EDTA compared to
less than 3% in cells from either COX-1COX-2 or WT
groups. Unlike the cells from COX-1COX-2 and WT mice
(which passaged for more than 10 generations), even passage
4 RMICs were not derived successfully from COX-2 KO
mice. The results are consistent with previous reports that
COX-2 plays important role in RMIC survival.16,33
Consistent with our analysis of transcripts in the renal
medulla of animals on a HSD (Figure 3), exposure of RMICs
to hypertonic conditions (using addition of NaCl and
mannitol to the culture medium) induced expression of
COX-2 in WT cells and of COX-1 in those derived from
COX-1COX-2 mice (Figure 6A). The capacity of these
cells to make PGs was augmented by 630 mOsm/kg H2O
(Figure 6B); again, PGE2 is the most abundant product.
Although the capacity to form PGI2 is modest in these cells,
induction of its formation is evident. Like PGE2, deletion of
COX-2 depresses significantly RMIC production of PGI2.
Substitution of COX-1 for COX-2 in the COX-1COX-2
mice differentially rescued PG formation under hyperosmolar
conditions. Thus, whereas 81%, 75%, and 60% capacity to
form PGE2, PGD2, and PGF2, respectively, was restored,
COX-1 compensated only one-third of the capacity to form
PGI2 (measured as 6-keto-PGF1).
Expression of the IP receptor in the renal medulla is largely
restricted to the vasa recta.34,35 Primary endothelial cells
(ECs) and RMICs from same mice were grown in a transwell
coculture system to address the possibility of paracrine
signaling from RMICs via endothelial IPs. RMICs in the
transwell insert were preincubated in media of high osmola-
lity (630 mOsm/kg H2O) to induce COX-2 expression, and
intracellular cAMP (as a surrogate measure of IP activation)
was quantified in ECs grown in the bottom chamber. Again,
all PGs released from RMICs from WT in the coculture
medium were augmented significantly by hypertonic stress.
COX-1 replacement failed to recapitulate PGI2 induction
(measured as 6-keto-PGF1) in RMICs from COX-1COX-2
mice (Online Figure VI, A). Correspondingly, cAMP produc-
tion of WT ECs was increased by 2.8-fold in response to
stressed RMICs (from 3.60.27 to 9.81.48 pmol/105 cells,
n6; Online Figure VI, B), whereas only minimal cAMP in
ECs from COX-1COX-2 mice was detected (0.220.01 to
0.250.03 pmol/105 cells; Online Figure VI, B), and that was
not increased by high osmolality. The cAMP response of ECs
to cicaprost, did not differ between WT and mutant mice,
demonstrating the capacity of the IP to generate the measured
Figure 5. HSD decreases the medullary IP
receptor expression in COX-1COX-2, COX-2,
and WT mice. A, IP mRNA levels in medulla
from COX-1COX-2, COX-2 KO, and WT mice
were quantitated by real time RT-PCR. HS indi-
cates HSD treatment. #P0.05 vs normal diet;
*P0.05 vs WT controls (n4 to 6). B, Repre-
sentative Western blot of medullary IP receptor
in COX-1COX-2, COX-2 KO, and WT mice. N
indicates normal salt diet; H, HSD. C, Relative
level of IP protein to -actin expression.
#P0.05 vs normal diet (n4).
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signal. These observations are consistent with aberrant IP
receptor signaling in the vasa recta in COX-1COX-2 mice.
Natriuresis Evoked by Activation of the Renal
Medullary IP Receptor
The IP agonist cicaprost (10 ng/20 L per hour) significantly
and progressively increased urine volume from 0.690.09
L/min (basal level, before infusion) to 1.670.10 L/min
(P0.01; Figure 7A) and urinary sodium excretion from
0.0950.002 Eq/min (basal level) to 0.16880.005 Eq/
min (P0.01; Figure 7B) over 2 hours of direct intramedul-
lary infusion. In contrast, no significant effects on urine
volume were observed over the same period during infusion
of vehicle control (0.670.12 L/min versus 0.740.05
L/min, PNS, n4). Thus, activation of the renal medul-
lary IP is capable of evoking natriuresis.
Discussion
Both tNSAIDs and NSAIDs purposefully developed to in-
hibit selectively COX-2 (pdNSAIDs) can elevate BP.3 Vaso-
Figure 6. COX protein expression and
PG production by cultured RMICs from
COX-1COX-2 and WT mice. RMICs
grown to subconfluence were subjected
to gradual changes in media osmolality
from 330 to 630 mOsm/kg H2O. After 24
hours, the cells were incubated with ara-
chidonic acid (20 mol/L) for 15 min-
utes. The cell lysates were prepared for
Western blot of COX-1 and COX-2 (A),
and the supernatants underwent PG
analysis (B) by mass spectrometry.
*P0.05 vs WT; #P0.01 vs 330
mOsm/kg H2O group (n6; repeated 3
times).
Figure 7. Activation of the IP by cicaprost
evokes natriuresis in anesthetized mice.
The right kidney was removed 1 week
before the experiment. The mice were
anesthetized and catheterized as
described in Methods. After 1 hour of
equilibration, cicaprost (10 ng/h) was
infused into the renal medulla over 120
minutes. Urine was collected every 30
minutes before and during cicaprost infu-
sion. Urine volume (UV) (A) and urinary
sodium excretion (UNaV) (B) were deter-
mined. Values presented as meansSEM.
*P0.05 vs basal level (n6).
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dilator PGs, such as PGI2 and PGE2, are critical to the
preservation of renal blood flow in renoprival conditions4,25
and COX-2 is the dominant source of biosynthesis of PGI2, as
assessed by excretion of its major urinary metabolite in
humans and in mice.11,36 Deletion of the IP results in
salt-sensitive hypertension19,20 and an increased sensitivity to
thrombogenic stimuli,11 whereas mutations of the IP and PGI2
synthase have been associated with hypertension and cardio-
vascular events in humans.37,38 Both COX-2 and COX-1
contribute to PGE2 formation11 and deletion of at least one of
the EPs (the EP2) coupled, like the IP, to adenylate cyclase
activation,34 also results in salt-sensitive hypertension.21,22 By
contrast, activation of other PGE2 receptors (EP1 and EP3)
elevates BP39,40 and activates platelets,41 respectively, in
rodents. Thus, PGI2 and PGE2 differ with respect to their
relative derivation from COX-2 and their receptor dependent
impact on cardiovascular function. Deletion and pharmaco-
logical inhibition of the COX isozymes suggests that their
products have opposite effects on BP,10 just as in hemostasis3;
thus, the likelihood of a hypertensive response to any NSAID
may relate both to inhibition of COX-2 and the selectivity
with which it is attained.12 Large scale clinical trials to
address this hypothesis have not been performed. An over-
view analysis of 19 trials suggested that hypertension was
more likely with pdNSAIDs than tNSAIDs. However, these
trials were small and heterogeneous with respect to both
groups of NSAIDs. Also, many tNSAIDs, such as diclofenac
and meloxicam, are similarly selective to the pdNSAID
celecoxib for inhibition of COX-2.42
The COX isozymes differ quite dramatically with respect
to their transcriptional regulation.1 These COX-1COX-2
mice23 permit assessment of whether harmonization of regu-
latory control allows rescue of COX-2 deficiency by COX-1.
Our results suggest that COX-2 plays a unique role in
maintaining BP homeostasis and that this relates to its
preferential linkage to biosynthesis of renal medullary PGI2.
The hypertensive response to NSAIDs is quite heteroge-
neous in humans43 and is markedly influenced by genetic
strain in mice.44 The precise genetic modifiers of this re-
sponse remain to be identified. Here we studied mice on a
mixed C57BL/6 x Sv129 background, that exhibit hyperten-
sion after pharmacological inhibition or genetic deletion of
COX-2 when maintained on regular chow.11 COX-2 plays
important roles in development26 and mice deficient in
COX-2 typically exhibit renal hypoplasia and biochemical
evidence of renal compromise. Here, COX-1 can rescue the
developmental effects, hypertension and hyporeninemia of
COX-2 KOs under such physiological conditions. By con-
trast, COX-1 was unable to compensate for the impact of
COX-2 deletion when the mice were exposed to the hyper-
tensive stimulus of a HSD.
This response to a HSD reflects a selective impact on the
medullary COX-2/PGI2 biosynthetic/response pathway that
mediates natriuresis. Evidence in the present study suggesting
that COX-2 is uniquely coupled to synthesis of PGI2 derives
from metabolite measurement in vivo and estimates of the
capacity to generate PGs in both kidney medulla and RMICs.
Previous observations that PGI2 was preferentially produced
through COX-2 in macrophages,45 ECs,46 and COX/PGI
synthase cotransfected HEK293 cells47 are also consistent
with this notion. COX-1 cannot compensate for the failure to
augment PGI2 formation in response to a HSD. This effect is
likely amplified by the unexpected depression by the HSD of
IP transcript and protein, uniquely among the PG receptors.
Indeed, COX-2 deficiency in the mutant mice may have
further augmented this effect, attaining significance at the
level of IP mRNA.
Renal medullary COX-2 has previously been implicated in
buffering the hypertensive response to dietary salt intake.17,18
Both COX isoforms are abundant in medulla, but they are
distributed differentially. COX-1 is expressed in both the
medullary collecting duct and in RMICs.10,14,15 COX-2 is
most prominent in RMICs, which are involved in the main-
tenance of the medullary microcirculation and urinary salt
excretion.10 Although the renal papilla receives less than 1%
of total renal blood flow, primarily through the descending
vasa recta,48 medullary blood flow promotes renal salt excre-
tion, so called pressure natriuresis.48
Deletion of either the IP19,20 or EP2 receptors21,22 results in
salt-sensitive hypertension, whereas deletion of the EP140 and
PGF2 receptor (FP)49 reduces BP. IP receptors are expressed
abundantly in the renal vasculature. IPs in the vasa recta34,35
can indirectly modulate sodium reabsorption by altering
blood flow to the adjacent medullary thick ascending limbs
and collecting ducts.50,51 Expression of the EP2 is also
evident in the vasa recta,52 where it too plays an important
role in maintaining fluid and electrolyte balance and
BP.21,22,25 Indeed, PGE2 is the most abundant PG product in
the measurements of biosynthetic capacity in renal medulla
and RMICs. However, unlike PGI2, both systemic and renal
medullary synthesis of PGE2 can be rescued by COX-1 and
rescue of PGE2 is much more efficient than of PGI2 in
RMICs. Thus, PGI2 is the COX-2 product more directly
implicated in the preservation of BP homeostasis in response
to dietary salt.
Placebo-controlled trials have revealed a cardiovascular
hazard attributable to pdNSAIDs.3 Although a predisposition
to thrombosis is dominant, hypertension and cardiac failure
are also evident in the spectrum of this cardiovascular risk.53
Multiple lines of evidence suggest that the risk of thrombosis
is attributable to suppression of COX-2 dependent PGI2.24,54
The present results integrate this mechanism with a predis-
position to hypertension and provide in vivo evidence to
support the notion that COX-2 is preferentially coupled to
biosynthesis of PGI2.
In summary, these results suggest that dysregulated expres-
sion of the COX-2–dependent, PGI2 biosynthesis/response
pathway in the renal internal medulla undermines the homeo-
static response of BP to a HSD. Inhibition of this pathway
may contribute directly to the hypertensive response to both
pdNSAIDs and tNSAIDs in humans.
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Supplement Meterial 
Animal husbandry Animals were maintained on a 12-hour light/12-hour dark cycle with 
normal mouse chow (0.7% NaCl) and water provided ad libitum. As for high salt 
challenge, mice were fed with 8% NaCl chow diet for 2 weeks. All COX-1>COX-2 and 
COX-2 null mice used for the experiments were initially produced on a mixed C57BL/6 x 
Sv129 genetic background (50%:50%). Both genotypes had been individually maintained 
using a heterozygous by heterozygous cross breeding strategy for more than 20 
generations. 
The effect of Cicaprost on salt sensitive hypertension in mice 8-10 week old COX-
1>COX-2 mice were randomly divided into two groups. One group was administered 
Cicaprost (50 μg/kg/d in 10 mM Tris/0.15 M NaCl solution, provided by Bayer Schering 
Pharma AG) subcutaneously via Alzet osmotic mini-pumps (model 2004) as described 
previously1, another group received vehicle solution as a control (10 mM Tris/0.15 M 
NaCl solution). A HSD (8% NaCl) was initiated after implantation of osmotic mini-
pumps and fed for an additional two weeks; blood pressure was recorded routinely by 
tail-cuff before mini-pump implantation and after HSD. 
RMIC cell culture RMICs were isolated from male mice (10 weeks old) using a 
standard method described by Fontoura et al 2.  Medullary regions of kidney containing 
inner medulla and inner zone of the outer medulla were dissected. The dissected tissue 
was finely minced in Hanks’ balanced salt solution (HBSS), then was digested with 170 
unit/ml collagenase type I for 45 min at 37°C (Washington Biochemical). The digested 
tissue were further sieved through 105 um mesh before re-suspended in a 1:1 mixture of 
culture medium RPMI 1640 (20% fetal calf serum, 0.66 U/ml insulin, 2 g/l NaHCO3, 
15mM Hepes, 250 ug/l amphotericin B) and Dulbecco’s modified Eagle’s medium 
(DMEM: 10% fetal calf serum, 3.7 g/l NaHCO3, 0.66 U/ml Insulin, 15mM Hepes, 250 
ug/l amphotericin B) conditioned by 3T3 Swiss albino mouse fibroblasts in the log phase 
of growth. Cells were maintained at 37°C in 95% O2-5% CO2 incubator. These cells 
exhibited characteristic abundant oil red-O–positive lipid droplets. Cells were typically 
studied at their 3rd and 4th passages. 
Culture medium osmolality could be modulated by adding extra NaCl and mannitol. The 
final concentration of NaCl and mannitol at 630 mOsm/kg.H2O and 930 mOsm/kg H2O 
are 0.08 M and 0.1 M, 0.16 and 0.2, respectively. As for low osmolality of 230 
mOsm/kg.H2O, the culture medium was diluted 2:3 with distilled water. Once the desired 
osmolality was achieved, the cells were incubated for 24 h for further experiment. 
Primary endothelial cell (EC) culture ECs were prepared from 6 week-old mice as 
previously discribed3. Briefly, lungs from two mice each group were harvested,  minced 
finely and digested in collagenase (Worthington Biochemical Co, 200 U/ml) at 37°C for 
45 minutes. After dissociated by titurating and filtered through a 100 μm disposable cell 
strainer (Becton Dickinson Labware), the lung cells were incubated with PECAM-1-
coated beads (ratio: 1.5μg antibody to 107 beads) for 20 min at at 4°C, then recovered by 
magnetic separator and seeded in complete culture medium in 60 mm dish. When the 
cells reached 70 to 80% confluence (around 3 days), a 2nd sort by ICAM-2-coated beads 
was applied to get 99% EC purity4. Passage 3 cells were used for co-culture experiments.  
RMIC/EC transwell co-culture and cellular cAMP Measurement 5 × 104 RMICs and 
3 × 105 ECs each well were seeded in Transwell Insert (0.4 um pore, 12 Well, Corning 
Incorporated) and regular 12-well plate (Corning Incorporated), respectively. 
Indomethacin (10μM, Sigma) was included overnight in the EC medium to block 
endogenous PGs before co-culture. RMICs were changed to high osmolality medium 
(630 mOsm/kg.H2O) or containing 5 μg/ml LPS for 5 hours to upregulate COX-2 
expression, then placed over EC minelayers (1.5 ml/well serum-free medium containing 
1 mM isobutylmethylxanthine (IBMX), phosphodiesterase inhibitior) and incubated for 
additional 2 hours. The serum-free medium was collected for PG analysis; cellular cAMP 
in cultured EC was extracted with ice-cold 65% ethanol for 30 min and then 
quantified using a radioimmunoassay kit (Amersham) according to the manufacturer’s 
instructions. 
Western blotting Cultured RMICs were washed with PBS and harvested in NuPAGE 
lysis buffer (invitrogen) followed by repetitive aspiration using a 27-gauge needle. 
Protein (10 µg) was loaded into each lane, separated on 4-10% BisTris-NuPAGE gels 
(Invitrogen) and transferred to Hybond ECL nitrocellulose membranes (Amersham 
Biosciences). Rabbit anti-COX-1 polyclonal antibody (Cayman Chemical Co.) at a 1:500 
dilution, rabbit anti-COX-2 polyclonal antiserum (Cayman Chemical Co.) at a 1:1000 
dilution, Rabbit anti-IP receptor polyclonal antibody (Cayman Chemical Co.) at a 1:500 
dilution, and mouse anti-β-actin monoclonal antibody (Sigma) at a 1:5000 dilution were 
used as primary antibodies. Horseradish peroxidase-conjugated goat anti-mouse IgG 
(Sigma) at 1:5000, and horseradish peroxidase-conjugated goat anti-rabbit IgG (Sigma) at 
a 1:2000 dilution, were used as secondary antibodies, respectively. Signals were detected 
by ECL (Amersham Biosciences).  
PG extraction and measurement Slices of inner medulla were carefully dissected and 
homogenized in 1 ml of ice cold PBS containing 100μM indomethacin using stainless 
steel beads (Qiagen). Residual tissue was separated by centrifugation, and the supernatant 
was collected. For PGs from cultured RMICs, cells were incubated with 30 μM 
arachidonic acid (AA, Cayman Chemical Co.) in PBS for 15 minutes. Either the 
supernatant from fresh tissues or culture medium was spiked immediately with 5ng 
PGD2-d4 (Cayman Chemical Co, Cat# 312010), TxB2-d4 (Cayman Chemical Co, Cat# 
319030), 6-keto Prostaglandin F1α-d4 (Cayman Chemical Co, Cat# 315210), PGF2α-d4 
(Cayman Chemical Co, Cat# 316010), PGE2-d4 (Cayman Chemical Co, 314010), then 
purified by solid phase extraction using StrataX C18 cartridges (Phenomenex). The solid 
phase extraction cartridge was conditioned with 1 ml of acetonitrile and equilibrated with 
1 ml of water. The sample was applied to the cartridge, which was then washed with 1 ml 
of 5% acetonitrile in water and dried with vacuum for 15 min. The analyte and internal 
standards were eluted from the cartridge using 1 ml of 5% acetonitrile in ethyl acetate. 
The eluate was collected and dried under a gentle stream of nitrogen. The resulting 
residue was reconstituted in 200 μl of 5% acetonitrile in water and filtered by 
centrifugation using 0.2-μm Nylon Microspin filters (Alltech Associates), then 
quantitated utilizing liquid chromatography/mass spectrometry/mass spectrometry 
(LC/MS/MS) analyses as described previously5. 
Urinary PG metabolite analysis 24-hour urines from male mice (8-10 weeks) were 
collected using metabolic cages and prostanoid metabolites were extracted and 
quantitated as previously described6.  
RNA isolation. Total RNA was extracted from tissues using RNeasy Mini-Kit (Qiagen). 
Reverse transcription was carried out on 400ng of RNA using Taqman Reverse 
transcription reagents (Applied Biosystems). The resulting cDNA was used for 
quantitative real time PCR.  
Quantitative real time PCR TaqMan gene expression assays (Applied Biosystems, 
Foster City, Calif; catalog No. 4331182) for RENIN (Mm02342889_g1), COX-1 
(Mm01336806_m1), COX-2 (Rn00568225_m1), EP1 (Mm00443098_g1), EP2 
(Mm00436051_m1), EP3 (Mm00441045_m1), EP4 (Mm0043053_m1), FP 
(Mm00436055_m1), IP (Mm00801938_m1), TP (Mm00436917_m1), DP1 
(Hs00235003_m1), DP2 (Rn00824628_m1) were performed on an ABI Prism 7900 
Sequence Detection System. Results were normalized with 18S rRNA (Hs99999901_s1). 
Histopathological Analysis Kidney and intestine were fixed in 10% buffered formalin 
for 24 h, processed routinely, and embedded in paraffin and stained with hematoxylin and 
eosin routinely. 
Plasma BUN and creatinine Analysis Blood collected from the saphenous vein was 
analyzed for BUN levels by the clinic laboratory of the Veterinary Hospital of University 
of Pennsylvania. 
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Online Figure I.  Comparison of blood pressure of WT mice from COX-1>COX-2 
heterozygous mating and COX-2 heterozygous mating at normal chow diet and high 
salt diet. Mice (6 weeks old) were fed either normal diet (0.7% NaCl) or high−salt diet 
(8% NaCl) for 2 weeks, blood pressure was measured by tail-cuff method. Wt Ctl, Wild 
type controls. N=10-11, p=n.s. 
BA
Online Figure II. Normal renal function in COX-1>COX-2 mice after high salt intake. 
Mice (6-7 weeks old) were fed high salt diet (8% NaCl) for 4 weeks, plasma and kidney samples 
were collected for renal function analysis. A. Plasma blood urea nitrogen (BUN) and creatinine in 
WT, COX-1>COX-2 and COX-2 KO mice. *P<0.05 vs COX-1>COX-2 and WT mice, n=5-8.
B. Representative light photomicrographs  of HE stained kidney sections from WT, COX-1>COX-2
and COX-2 mice after high salt treatment. Upper panel, 20X magnification; Lower panel, 400X
magnification. Dotted lines represent the thickness of cortex. Black arrow, hypoplastic glomeruli near 
capsular surface .
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Online Figure III. Effect of high salt intake on PG receptor expression in inner 
medulla region in COX-1>COX-2, COX-2 and WT mice.  EP receptors (A, B, C, D), 
DP2 (E), FP (F) and TP (G) mRNA level in medulla from COX-1>COX-2, COX-2 KO 
and WT mice were quantitated by real time RT-PCR; HS, High salt diet treatment.  *, 
p<0.05 vs WT controls, n=4-6 
 
 
 
Online Figure IV.  TP (A) and IP (B) expression in renal cortex of COX-1>COX-2, 
COX-2 KO and WT mice before and after high salt treatment. TP and IP receptor in 
renal cortex from COX-1>COX-2, COX-2 and WT mice were quantitated by real time 
RT-PCR; HS, High salt diet treatment (2 wks). *, p<0.05 vs WT controls, n=4-6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Figure V. The effect of Cicaprost on salt induced hypertension in COX-
1>COX-2 mice.  COX-1>COX-1 mice were infused subcutaneously either Cicaprost 
(50μg/kg/d in 10 mM Tris/0.15 M NaCl solution) or Vehicle (10 mM Tris/0.15 M NaCl 
solution) through Alzet osmotic mini pimps, and then subject to High salt diet (HSD) for 
2 weeks. Blood pressure was recorded before implantation (Normal chow diet) and after 
HSD treatment.  *, p<0.01 vs Normal diet; #, p<0.01 vs Vehicle group, n=9. 
 
 
Online Figure VI.  RMIC COX2 derived PGI2/IP signaling was impaired in co-
cultured vascular endothelial cells (ECs).  RMICs in Transwell Inserts (Corning 
Incorporated) was sustained in either 330 or 630 mOsm/kg.H2O  culture medium for 5 
hrs, then co-incubated with 1  mM isobutylmethylxanthine (IBMX) pretreated primary 
ECs for additional 2 hrs. The EC media were subjected to PG analysis (A) and cellular 
cAMP was assayed in cultured ECs (B). Cica, 1μM Cicaprost was used directly in 
IBMX-treated ECs medium as a positive control for IP activation. *, p<0.05 vs WT group; 
#, p<0.01 vs 330 mOsm group, n=6. 
